x

Posted 02 April, 2024

Bluejay Diagnostics, Inc. appointed new CEO

CEO Change detected for ticker Nasdaq:BJDX in a 8-K filed on 02 April, 2024.


  In connection therewith, Frances Scally, who had served as the Company's Interim Chief Financial Officer pursuant to such agreements with DLA, ceased serving as an officer of the Company. In connection with these matters, the Board of Directors of the Company (the "Board") has designated Neil Dey, the Company's President and Chief Executive Officer, as the Company's the principal financial and accounting officer, in addition to serving as principal executive officer.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Bluejay Diagnostics, Inc.
Health Care/Life Sciences • Medical Equipment/Supplies
Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.
Market Cap
$986K
View Company Details
Bluejay Diagnostics, Inc. by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On March 29, 2024, Bluejay Diagnostics, Inc. (the "Company") provided notice to DLA, LLC ("DLA") that the Company has terminated the scope of work and master services agreement between the Company and DLA, effective immediately. In connection therewith, Frances Scally, who had served as the Company's Interim Chief Financial Officer pursuant to such agreements with DLA, ceased serving as an officer of the Company. In connection with these matters, the Board of Directors of the Company (the "Board") has designated Neil Dey, the Company's President and Chief Executive Officer, as the Company's the principal financial and accounting officer, in addition to serving as principal executive officer.